Codiak BioSciences, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price
Codiak BioSciences, Inc. had Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price of $10.79 per share as of 2022-09-30, per its 10-Q filed 2022-11-03.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice · last filed 2022-11-03
- 2022-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price $10.79.
- 2022-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price $11.03.
- 2022-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price $11.59.
- 2021-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price $12.56.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price |
|---|---|
| 2022-09-30 | $10.79 10-Q · filed 2022-11-03 |
| 2022-06-30 | $11.03 10-Q · filed 2022-08-04 |
| 2022-03-31 | $11.59 10-Q · filed 2022-05-05 |
| 2021-12-31 | $12.56 10-Q · filed 2022-11-03 |
| 2021-09-30 | $12.68 10-Q · filed 2021-11-04 |
| 2021-06-30 | $11.88 10-Q · filed 2021-08-05 |
| 2021-03-31 | $11.26 10-Q · filed 2021-05-06 |
| 2020-12-31 | $8.52 10-K · filed 2022-03-10 |
| 2020-09-30 | $8.47 10-Q · filed 2020-11-19 |
| 2019-12-31 | $7.78 10-K · filed 2021-03-17 |